Détail de l'auteur
Documents disponibles écrits par cet auteur (280)
Rapport
FRANÇAIS : Ce rapport de l'OEDT offre un tour d'horizon du phénomène de la toxicomanie en Europe : il fournit des renseignements sur les différents types de consommation, des données comparatives d'ordre épidémiologique ou encore des chiffres [...]Rapport
Cette première édition révèle que le problème de drogue dans ces pays diffère radicalement de la situation d'il y a cinq à sept ans. Traditionnellement considérés comme des pays de "transit", ils sont devenus aujourd'hui une cible pour ce qui co[...]Rapport
This publication presents the data and findings of the risk assessment on 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC), carried out by the extended Scientific Committee of the EMCDDA on 19 November 2021. On the b[...]Rapport
This publication presents the data and findings of the risk assessment on 2-(methylamino)-1-(3-methylphenyl)propan-1-one (3-methylmethcathinone, 3-MMC), carried out by the extended Scientific Committee of the EMCDDA on 18 November 2021. On the b[...]Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 4-methylamphetamine, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant drug[...]Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 4-methylamphetamine, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant drug[...]Rapport
This publication presents the data and findings of the risk assessment on N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide (4F-iBF), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017. I[...]Rapport
This risk assessment report presents the summary findings and the conclusion of the risk assessment carried out by the Scientific Committee of the EMCDDA on 4F-MDMB-BICA. The report is intended for policymakers and decision-makers in the institu[...]Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 5-(2-aminopropyl)indole, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant [...]Rapport
This publication presents the data and findings of the risk assessment on methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA), carried out by the extended Scientific Committee of the EMCDDA on 7-8 N[...]Rapport
This publication presents the data and findings of the risk assessment on N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA), carried out by the extended Scientific Committee of the EMCDDA on 7-8 No[...]Rapport
This publication presents the data and findings of the risk assessment on N-(1 phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 22 February 2017. On the basis of th[...]Rapport
This publication presents the data and findings of the risk assessment on N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA), carried out by the extended Scientific Committee of the EMCDDA on 7[...]Rapport
Based on the options provided by the international drug control legal framework, this paper considers the rehabilitative measures of treating, educating or reintegrating drug users as alternatives or additions to conviction or punishment that ar[...]Chapitre
OEDT = EMCDDA | 2012FRANÇAIS : Dans nombre de pays européens, les amphétamines (terme générique regroupant l'amphétamine et la méthamphétamine) ou l'ecstasy sont la deuxième drogue illicite la plus répandue. En outre, dans certains pays, la consommation d'amphétam[...]Rapport
This report presents new findings from the ESCAPE (European Syringe Collection and Analysis Project Enterprise) network, based on the chemical analysis of the contents of used syringes across sentinel sites in Europe. Syringes were collected in [...]Rapport
OEDT = EMCDDA ; A. HEINEMANN ; S. IWERSEN-BERGMANN | Lisbon : OEDT / EMCDDA | Technical reports | 2019The objective of this report is to provide an updated analysis of the post-mortem toxicology practices of drug-related deaths (DRD) in Europe and to discuss the effect of these practices on the monitoring of DRDs. It is based on the results of a[...]Rapport
OEDT = EMCDDA ; M. CLAESSENS ; W. HARDYNS ; F. VANDER LAENEN ; N. VERHAEGHE | Lisbon : OEDT / EMCDDA | 2019The production of synthetic drugs, measured by the number of manufacturing sites identified and the amount of drugs seized, shows an increasing trend. In the Netherlands, Schoenmakers and Mehlbaum (2017) recorded a rise in the number of sites us[...]Rapport
Online anonymous marketplaces are a relatively recent technological development that enables sellers and buyers to transact online with far stronger anonymity guarantees than are available on traditional electronic commerce platforms. This has l[...]Rapport
OEDT = EMCDDA ; S. CASTIGLIONI, Éditeur scientifique ; L. VANDAM ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2016"Assessing illicit drugs in wastewater: advances in wastewater-based drug epidemiology" reviews a new approach to estimating drug use in populations, based on the detection and quantification of drugs and their metabolic products in community wa[...]Rapport
This report reviews how opioid substitution treatment (OST) is implemented in European countries and examines the public health consequences of the diversion and misuse of prescription OST medications. It looks at how OST medications are diverte[...]Chapitre
OEDT = EMCDDA | 2012FRANÇAIS : Le cannabis est la drogue illicite la plus largement répandue en Europe, où elle est tout à la fois importée et produite. Dans la plupart des pays d'Europe, la consommation de cannabis a augmenté durant les années 1990 et au début de[...]Rapport
This publication answers some of the more frequently asked questions raised in discussions about cannabis legislation. While the primary focus is on the use of cannabis for recreational purposes, relevant legislation for other uses, including me[...]Rapport
At a time of increased debate on the laws controlling the use of cannabis in the European Union, this report answers some of the questions most often asked about cannabis legislation. Using a question and answer format, basic definitions and the[...]Rapport
OEDT = EMCDDA ; C. CARPENTIER ; K. MULLIGAN ; L. LANIEL ; D. J. POTTER ; B. HUGHES ; L. VANDAM ; D. OLSZEWSKI ; K. SKARUPOVA | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2012FRANÇAIS : « La part de marché de l'herbe de cannabis augmente en Europe, aux dépens de celle de la résine de cannabis ». Telle est l'information qui ressort de la première analyse détaillée de la Production et des marchés du cannabis en Europe[...]Livre
OEDT = EMCDDA ; S. R. SZNITMAN ; B. OLSSON ; R. ROOM, Éditeur scientifique | Lisbon : OEDT / EMCDDA | Monographs, ISSN 1606-1691 | 2008FRANÇAIS : A l'occasion de la Journée internationale contre l'abus et le trafic de drogues le 26 juin 2008, l'OEDT publie sa monographie scientifique la plus importante à ce jour. Dans ce document de plus de 700 pages, des experts renommés eur[...]Rapport
OEDT = EMCDDA ; CCSA (Canadian Centre on Substance Use and Addiction) (Ottawa, ON) | Lisbon : OEDT / EMCDDA | Joint publications | 2018FRANÇAIS : Avec l'usage de cannabis et les politiques le concernant en constante évolution dans le monde entier, la drogue au volant est devenue un enjeu politique de taille. Le présent document s'adresse aux responsables de l'élaboration de po[...]Rapport
OEDT = EMCDDA ; L. LANIEL ; M. GANDILHON ; J. E. ADES ; A. CUNNINGHAM ; N. SINGLETON ; R. SEDEFOV ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2018Captagon is reported to be a commonly used stimulant in the Middle East. In addition, some recent media reports have linked this drug to perpetrators of terrorist acts in Europe or terrorist groups based in areas of conflict in the Middle East. [...]Rapport
This publication presents the data and findings of the risk assessment on methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2[...]Rapport
FRANÇAIS : Entre mars et mai 2021, le projet EU4Monitoring Drugs (EU4MD) a permis de cartographier les systèmes nationaux de prévention dans les pays de la zone de la politique européenne de voisinage (PEV). Cette note d'information décrit la [...]Rapport
ENGLISH : Social reintegration is an intervention which aims at integrating the client into the society through either education, work or housing. Traditionally, social reintegration was seen as an intervention subsequent to the (successful) c[...]Rapport
This workbook is part of a series intended to educate programme planners, managers, staff and other decision-makers about the evaluation of services and systems for the treatment of psychoactive substance use disorders. The objective of the seri[...]Rapport
OEDT = EMCDDA ; L. MONTANARI ; M. PASINETTI ; D. THANKI ; J. VICENTE | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2013Identifying the co-occurrence of drug use and mental health disorders in the same individuals is essential for effective treatment of their drug use problems. Reviewing the available information on psychiatric co-morbidity among drug users in Eu[...]Rapport
Rapport
FRANÇAIS : Dans cette Question spécifique, publiée en marge de son Rapport annuel 2007, l'OEDT montre que, dans certains pays européens, on a observé au cours de ces dernières années une augmentation significative de la consommation de cocaïne[...]Chapitre
OEDT = EMCDDA | 2012FRANÇAIS : La cocaïne reste la deuxième drogue illicite la plus consommée dans l'ensemble de l'Europe, bien que les niveaux de prévalence et les tendances varient considérablement entre les pays. Des niveaux élevés de consommation de cocaïne ne[...]Document texte divers
FRANÇAIS : Ces données sur les consommations sont extraites du rapport de l'OEDT. Parmi les tendances les plus marquantes, le rapport constate que la cocaïne devient la drogue stimulante de premier plan pour les jeunes européens, les quantités[...]Rapport
Community coalitions are a strategy to coordinate activities and resources to prevent adolescent substance use and delinquent behaviour. They can help mobilise communities in prevention and health promotion initiatives. The Communities That Car[...]Chapitre
FRANÇAIS : La cooccurrence d'une maladie psychiatrique et de troubles dus à l'usage de substances, communément appelée comorbidité ou double diagnostic, n'est pas un phénomène nouveau. Toutefois, ces dernières années, cette question a gagné du [...]Rapport
OEDT = EMCDDA ; M. TORRENS ; J. I. MESTRE-PINTO ; A. DOMINGO-SALVANY ; L. MONTANARI ; J. VICENTE | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2015This publication looks at the co-occurrence of drug use problems and mental health disorders, taking in the theoretical background of psychiatric comorbidity, the tools for clinical diagnosis and the prevalence and clinical relevance of the prob[...]Rapport
The aim of the present report is to collect information from a literature review on computer-assisted interviewing and online data collection in general population surveys. It evaluates the pros and cons of both approaches in terms of research p[...]Rapport
This report presents the results and findings of a field trial conducted in 1999 on the treatment demand indicator. This field trial was conducted as part of a project which had the following aims: - putting together a standard protocol for th[...]Chapitre
FRANÇAIS : Les jeunes se situent souvent à l'avant-garde des mutations sociales, et la tendance à la hausse de la consommation d'alcool et de drogues illicites par cette tranche d'âge dans l'UE constitue une évolution importante de la société. [...]Chapitre
FRANÇAIS : La présence et la consommation de drogues ont fondamentalement modifié la réalité de la prison au cours des deux dernières décennies et, aujourd'hui, tous les pays européens connaissent des problèmes majeurs en matière de drogues et [...]Bulletin : Périodique
Objectif drogues, n°21 - Juillet 2011 - Consommation de khat en Europe : conséquences sur la politique européenne
OEDT = EMCDDA ; M. ODENWALD ; A. KLEIN ; N. WARFA | 2011FRANÇAIS : Les feuilles de khat se cultivent dans les régions montagneuses de la Corne de l'Afrique, dans le sud de l'Arabie et le long de la côte est de l'Afrique. Depuis des siècles, certaines populations d'Éthiopie, du Kenya, de la Somalie e[...]Chapitre
OEDT = EMCDDA | 2012FRANÇAIS : La consommation d'héroïne, en particulier par injection de la drogue, est étroitement associée à des problèmes sociaux et de santé publique depuis les années 1970. Aujourd'hui, cette drogue représente encore la part la plus important[...]Rapport
For the last 20 years, coordination in the field of drugs has been seen as an integral part of drug policy and an indispensable tool for ensuring its effectiveness. This thematic paper looks at the formal characteristics of drug coordination sys[...]Rapport
This Selected issue provides an exploratory European overview of costs associated with treatment for drug dependence. The cost of drug treatment in Europe is looked at from two main angles in this report. First, an overview is presented of the m[...]Rapport
OEDT = EMCDDA ; Inter-American Drug Abuse Control Commission of American States (CICAD-OAS) | Lisbon : OEDT / EMCDDA | Joint publications | 2010National drugs observatories have flourished and developed rapidly over the last two decades as a direct consequence of the decisions taken to establish regional drug monitoring systems, both in the European Union and in the Americas. Initially[...]Rapport
This publication presents the data and findings of the risk assessment on 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017.[...]Rapport
This publication presents the data and findings of the risk assessment on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 21 March 2018.[...]Rapport
Rapport
The trafficking of drugs and, in particular, the use of human carriers (often called 'drug mules') remains a relatively hidden phenomenon, on which limited information is available. This latest EMCDDA Thematic paper explores whether a common def[...]Chapitre
FRANÇAIS : La stratégie antidrogue de l'Union européenne (2000-2004) stipule que le Conseil et la Commission européenne devraient tenter de dresser une liste détaillée de toutes les dépenses publiques dans le domaine de la lutte contre la drogu[...]Rapport
This paper presents the EMCDDA's current thinking on the conceptual framework for monitoring drug markets, crime and supply reduction - building on the work completed in this area and expanding to reflect the academic research underpinning this [...]Rapport
OEDT = EMCDDA ; T. FREEMAN ; T. GROSHKOVA ; A. CUNNINGHAM ; P. GRIFFITHS ; D. POTTER ; S. CRAFT ; A. ENGLUND ; M. LYNSKEY ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2019ENGLISH: This paper provides an overview of established and emerging cannabis products in Europe. For each type of product, major issues in its production, distribution, use and effects on health are detailed. In doing so, the paper seeks to in[...]Rapport
OEDT = EMCDDA ; H. SCHULZE, Coordonnateur ; M. SCHUMACHER ; R. URMEEW ; K. AUERBACH ; J. ALVAREZ ; I. M. BERNHOFT ; H. DE GIER ; M. HAGENZIEKER ; S. HOUWING ; A. KNOCHE ; B. PILGERSTORFER ; B. ZLENDER ; B. HUGHES ; L. VANDAM | Lisbon : OEDT / EMCDDA | Thematic Papers, ISSN 1725-5767 | 2012This Thematic paper presents the key findings of the European Union’s research project on Driving Under the Influence of Drugs, Alcohol and Medicines, known as the DRUID project. The project looked at experimental studies, epidemiological studie[...]Rapport
A main aim of this report is to inform discussions on drug consumption rooms (DCRs) by examining the available evidence, as well as reviewing the various models being adopted and their characteristics. The report is based on a mixed-methods app[...]Rapport
One of the targets of the EU action plan is 'to reduce significantly over five years the prevalence of drug use, as well as new recruitment to it, particularly among young people under 18 years of age'. In total there are eight references to you[...]Rapport
FRANÇAIS : Les peines prononcées à l'encontre des délinquants pour des infractions liées à la drogue à travers l'Union européenne sont examinées pour la première fois dans la présente «Question spécifique». En analysant les statistiques les pl[...]Rapport
OEDT = EMCDDA ; A. O'GORMAN ; E. QUIGLEY ; F. ZOBEL ; K. MOORE | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2013This study explores the civil society organisations that engage in drug policy advocacy in Europe. An Internet search in English, French and Spanish combined with information from national sources in 30 countries identified 218 organisations act[...]Rapport
This paper describes the development and main characteristics of drug policy in Austria. It traces the development of Austrian drug laws from the time of the Austro-Hungarian Empire through to the present day. Austria's drug policy has several d[...]Rapport
This paper describes the development and main characteristics of drug policy in Poland. It starts with the early days of drug control in Poland in the 1920s, describes the changes related to the emergence of Polish heroin - Kompot - in the late [...]Rapport
OEDT = EMCDDA ; E. QUIGLEY ; B. HUGHES ; C. COSTA STORTI ; F. ZOBEL | Lisbon : OEDT / EMCDDA | Drug policy profiles, ISSN 1977-2246 | 2013The national drug policy of Ireland comes under the spotlight in the second volume in the EMCDDA series of Drug policy profiles. Examining the evolution of Irish drug policy through four periods of historic development, the report explores: the [...]Rapport
This paper describes the significant developments that have occurred in the last 5 to 10 years in the field of drug precursors related to synthetic stimulant drugs produced in the EU. This includes describing the 'pre-precursor' phenomenon and r[...]Rapport
This report considers substance use prevention in Europe through the lens of a system, highlighting the wide range of factors that need to be addressed to successfully implement substance use prevention programmes and policies. They are consider[...]Rapport
This Thematic paper contains the results of a study that examined drug prevention interventions for minority ethnic populations in 29 European countries. A total of 33 interventions were reported to the study and the issues they raise are presen[...]Rapport
This publication provides an update on drug-related deaths in Europe, presenting and analysing the latest data and trends in drug-induced deaths and overall mortality among high-risk drug users in the European Union and beyond. It draws on contr[...]Rapport
OEDT = EMCDDA ; I. GIRAUDON ; F. MATHIS ; D. HEDRICH ; J. VICENTE ; A. NOOR | Lisbon : OEDT / EMCDDA | Technical reports | 2021This report provides an update on drug-related deaths in Europe based primarily on presentations and discussions held at the 2019 meeting of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) expert network on drug-related deat[...]Rapport
This report is part of the EMCDDA activity around the development and improvement of drug supply indicators, which are designed to reflect developments in drug markets as well as the markets' wider harms and impact. The protocol in this document[...]Rapport
Homicide is a violent act that generates high social costs. In particular, drug-related homicide (DRH) has the potential to act as an indicator of wider drug-related crime. Comparing DRH levels between countries with data on this topic can be a [...]Rapport
OEDT = EMCDDA ; I. GIRAUDON ; A. M. DINES ; N. SINGLETON ; A. NOOR ; P. I. DARGAN ; D. WOOD | Lisbon : OEDT / EMCDDA | Technical reports | 2020ENGLISH: This report presents the latest findings on drug-related hospital emergencies from a network of sentinel hospitals across Europe. Almost 24 000 emergency presentations were recorded at 32 sentinel hospitals over the first 4 years of th[...]Rapport
This 2020 EMCDDA update on drug-related infectious diseases aims to provide a comprehensive overview of the current situation with regard to the epidemiological picture of drug-related infectious diseases in Europe up to January 2020, while high[...]Rapport
This report presents an overview of infectious diseases among people who inject drugs in Europe, both in the community and in prison settings, covering disease surveillance, outbreak investigations, and prevention and control, for the period up [...]Rapport
This report provides an update on infectious diseases related to injecting drug use in Europe. It covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and the responses in the area. The report [...]Rapport
This report provides an update on infectious diseases related to injecting drug use in Europe. It covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and the responses in the area. The report [...]Rapport
This report provides an update on infectious diseases related to injecting drug use in Europe for the period up to June 2015. The report covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and[...]Rapport
An update on the EMCDDA 2008 Selected Issue on drug-related research, this thematic paper identifies current and future challenges and opportunities for drug-related research in Europe.Rapport
OEDT = EMCDDA ; L. LANIEL ; R. KASECKER ; T. GROSHKOVA ; C. CARPENTIER | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2013Drug law enforcement activity targets the supply of drugs and is responsible for much of the key data that informs our understanding of drugs supply in Europe. This study looks, for the first time, at how drug law enforcement is organised in Eur[...]Rapport
OEDT = EMCDDA ; L. LANIEL ; T. SURMONT ; T. STOIAN ; S. ALM | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2017In 2014, the EMCDDA took the decision to carry out a limited follow-up study of the EMCDDA Paper Drug squads: units specialised in drug law enforcement in Europe (EMCDDA, 2013), with the aim of monitoring possible changes and trends in drug supp[...]Rapport
OEDT = EMCDDA ; E. QUIGLEY ; R. SEDEFOV ; C. CARPENTIER ; L. LANIEL ; European Commission, COWI Consortium for DG Health and Consumers | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2013The production and trafficking of illicit drugs poses complex and interlinked problems, which have a negative impact on public health and the security and stability of society. Focusing on actions directed at the EU's internal security situation[...]Rapport
OEDT = EMCDDA ; L. AMATO ; Z. MITROVA ; M. DAVOLI | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2017Although rare, drug testing in schools continues to be practised in some European countries. In many cases, drug testing is intended to act as a deterrent to substance use. Nevertheless, studies conducted in the United States show that the drug [...]Rapport
OEDT = EMCDDA ; R. KERT ; A. LEHNER ; B. HUGHES ; O. DALBINOE | Lisbon : OEDT / EMCDDA | Technical reports | 2017The results of a study on national drug trafficking laws and their application in the Member States of the European Union are presented in this report. It is based on an analysis of the national laws and on the opinions of legal practitioners - [...]Rapport
It is estimated that over 1 million people receive treatment for drug-related problems in the European Union every year. With shrinking public budgets, increasing pressure on health systems, changes in the drugs used and the need to provide on-g[...]Rapport
This report presents a summary of the key findings from drug treatment facility surveys carried out in 2017 in Albania, Bosnia and Herzegovina, Serbia and the territory of Kosovo. The results provide insight into the characteristics and capacity[...]Rapport
The result of the EMCDDA's cooperation with countries in the Western Balkans over many years, this report is the first of its kind. It gives insight into the drug-related problems faced by six countries in the region, through the available data [...]Rapport
OEDT = EMCDDA ; L. ROYUELA ; L. MONTANARI ; M. ROSA ; J. VICENTE | Lisbon : OEDT / EMCDDA | Technical reports | 2014The report presents a review of tools for monitoring illicit drug use in prison population in Europe. The objective of the report is to describe the existing tools used at national level, to assess their comparability and to build a common Europ[...]Rapport
Drug use is directly or indirectly prohibited in all EU countries - except for in medical or scientific circumstances - and punishment for offences varies from administrative to penal, depending on the country. This thematic paper analyses curre[...]Rapport
This joint report prepared by the EMCDDA and Europol considers the latest findings from international research, fresh empirical data, and operational information and intelligence in order to illuminate how darknet markets function and how they r[...]Rapport
FRANÇAIS : La politique sociale en Europe a depuis longtemps identifié les populations défavorisées qui courent un risque d'exclusion sociale. Ces «groupes vulnérables» désignent des groupes spécifiques au sein de la population, qui sont plus [...]Rapport
OEDT = EMCDDA ; K. SKARUPOVA ; T. NÉFAU ; E. LEFRANÇOIS ; T. SEYLER | Lisbon : OEDT / EMCDDA | Rapid communication | 2019This report presents the results of an innovative method for gathering information on the substances used by people who inject drugs. In this pilot study, chemical analysis of the contents of used syringes collected from exchange sites reveals t[...]Rapport
FRANÇAIS : Les problèmes liés à la drogue apparaissent souvent - et sont ressentis de la façon la plus aiguë - dans les environnements urbains, ce qui fait des villes d'Europe une précieuse fenêtre d'observation sur les nouvelles tendances du p[...]Rapport
Since the late 1990s, drug strategies and action plans have been increasingly adopted by EU countries as the central instrument for implementing drug policy. This thematic paper looks at the origins and characteristics of this phenomenon as well[...]Rapport
OEDT = EMCDDA ; A. GALLEGOS ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Thematic Papers, ISSN 1725-5767 | 2012This publication presents 30 profiles of the national early warning systems on new psychoactive substances in operation in Europe in 2011. The early warning system on new psychoactive substances is a multidisciplinary network consisting of 30 Eu[...]Rapport
European Centre for Disease Prevention and Control ; OEDT = EMCDDA | Lisbon : OEDT / EMCDDA | Joint publications | 2011FRANÇAIS : Sept interventions, un objectif : zéro infections parmi les personnes qui s’injectent des drogues. Dans un nouveau rapport d'orientation publié aujourd'hui, deux agences de l'UE, l'ECDC et l'OEDT, ont uni leurs efforts pour recenser [...]Congrès
The conference "Identifying Europes information needs for effective drug policy" marked the 15th anniversary of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), and our activity of monitoring drugs and drug addiction in the [...]Rapport
FRANÇAIS : De nouvelles substances psychoactives deviennent largement disponibles à un « rythme sans précédent ». En 2010, un nombre record de nouvelles drogues ont été officiellement signalées à l'OEDT et à Europol par le biais du système d'al[...]Rapport
FRANÇAIS : De nouvelles drogues ont été détectées dans l'Union européenne l'année dernière, à raison d'une par semaine environ, selon le rapport annuel conjoint de l'OEDT et d'Europol (2011) sur les nouvelles substances psychoactives publié auj[...]Rapport
FRANÇAIS : Le rapport annuel 2013 OEDT-Europol, qui fait le point sur les nouvelles drogues, indique que le nombre, le type et la disponibilité des nouvelles drogues en Europe ont continué à croître en 2012. Elles étaient au nombre de 49 en 201[...]Rapport
This report presents the key activities performed by the EMCDDA and Europol in 2013, with details on all the relevant activities in support of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and c[...]